Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

The obese group will enroll 500 people within 1 year of study initiation and follow-up annually. The control group will enroll 30 patients a year for 5 years.

Inclusion criteria

for the obese group

• Adults 19 years of age or older
• Obese patients with chronic diseases such as cardiovascular disease, hypertension, diabetes, and metabolic syndrome (BMI ≥ 25 kg/m2, [BMI ≥ 30 kg/m2, including 10% or more])

Inclusion criteria

for the control group

• Adults 19 years of age or older
• Those with BMI 18.5~24.9 kg/m2

Exclusion criteria

for the obese group

• Serious non-cardiovascular disease with life expectancy less than 6 months
• Pregnant or suspected of being pregnant or are lactating
• Patients within 3 months of organ transplantation
• Patients currently being treated for acute transplant rejection
• Patients treated for acute coronary syndrome (myocardial infarction, unstable angina) and discharged within 6 months
• Patients with acute cerebral infarction within 6 months of being hospitalized and discharged
• Type 1 Diabetes
• Patients taking steroids, female hormones
• Those who have difficulty using smartphones

Exclusion criteria

for the control group

• Serious non-cardiovascular disease with life expectancy less than 6 months
• Pregnant or suspected of being pregnant or are lactating
• Persons who are continuously taking medications prescribed by a doctor due to chronic diseases excluding hypertension and dyslipidemia
• Within 5 years of diagnosis of malignant tumor
• Those who have difficulty using smartphones